Johnson & Johnson, US4781601046

Johnson & Johnson stock at EUR 233.25 with P/ E 30.3

Published on 10/09/2026 at 19:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson stock costs EUR 233.25 on October 9, 2026, plus 2.53 percent versus its prior close. The 52-week USD range is 184.66 to 281.07.

Key points in brief

  • Johnson & Johnson stock was at EUR 233.25 at Lang & Schwarz on October 9, 2026, up 2.53 percent versus the prior close.
  • The NYSE quote was USD 261.11, with a 52-week range of USD 184.66 to USD 281.07.
  • Market capitalization stood at USD 629.2 billion and the price-to-earnings ratio was 30.25.
Modern hospital operating room with robotic surgical arms positioned above a draped patient, surgeons in blue sterile gowns monitoring vital-sign and anatomy screens, bright overhead surgical lighting, stainless steel instrument trays in the foreground
Johnson und US4781601046 zeigen modernen Krankenhaus OP mit Robotik Chirurgie und medizinischen Bildschirmen, Illustration mit AI erstellt.

At Lang & Schwarz, Johnson & Johnson stock was trading at EUR 233.25 on October 9, 2026 at 7:03 p.m. CEST, plus 2.53 percent versus its prior close. The move places the German-market quote below the stock's US session level, while keeping the price inside its established annual range.

Price sits 7.10 percent below high

The latest New York Stock Exchange quote was USD 261.11 at 1:05 p.m. EDT on October 9, 2026, up 1.81 percent from the previous close. The quote was 7.10 percent below the USD 281.07 52-week high, calculated from the same USD price and range, and 41.38 percent above the USD 184.66 low.

Lang & Schwarz listed a bid of EUR 233.10 and an ask of EUR 233.40 at 7:03 p.m. CEST. Trading volume on the NYSE was 1,917,097 shares against an average volume of 7,011,785 shares on October 9, 2026.

Valuation and earnings date

Johnson & Johnson carried a market capitalization of USD 629.2 billion and a price-to-earnings ratio of 30.25 on October 9, 2026. The valuation is measured against the latest market price and does not include a recommendation.

According to MarketBeat on October 8, 2026, Guggenheim reaffirmed a Buy rating in a research note issued on October 7 and set a USD 287.00 price target. That target lies 9.91 percent above the USD 261.11 NYSE quote. Finzer lists October 13, 2026 as the next earnings date.

Comparison with peers

Johnson & Johnson (Lang & Schwarz, EUR; NYSE, USD): plus 2.53 percent, P/E 30.25, market capitalization USD 629.2 billion
Pfizer (NYSE, USD): plus 1.15 percent, P/E 37.18, market capitalization USD 160.4 billion
Merck & Co. (NYSE, USD): plus 2.45 percent, P/E 116.66, market capitalization USD 360.3 billion

Trading snapshot for Germany

The Lang & Schwarz price stood at EUR 233.25 on October 9, 2026 at 7:03 p.m. CEST, plus 2.53 percent versus the Lang & Schwarz prior close of EUR 227.50 on October 8, 2026. The NYSE session was still open at the latest USD quote, so the two prices represent separate venues and currencies.

The further course of trading is shown by the continuously updated real-time quote of Johnson & Johnson stock.

Johnson & Johnson stock facts

  • Company: Johnson & Johnson
  • ISIN: US4781601046
  • Ticker: JNJ
  • Primary exchange: New York Stock Exchange
  • Price Lang & Schwarz (as of October 9, 2026, 7:03 p.m. CEST): EUR 233.25
  • Change versus prior close: plus 2.53 percent
  • Prior close Lang & Schwarz (October 8, 2026): EUR 227.50
  • Market capitalization: USD 629.2 billion (as of October 9, 2026)
  • 52-week range: USD 184.66-281.07 (as of October 9, 2026)
  • Sector / Industry: Healthcare / Drug Manufacturers - General
  • Next earnings date: October 13, 2026

Market context: Market report S&P 500.

More news and analyses on Johnson & Johnson stock

Disclaimer...

en | US4781601046 | JOHNSON & JOHNSON | boerse | 70282190 | bgmi